Theratechnologies Analyst Ratings
Theratechnologies Analyst Ratings
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 122.22% | Canaccord Genuity | → $2 | Assumes | → Hold |
| 11/17/2022 | 900% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 07/29/2021 | 233.33% | Canaccord Genuity | $8 → $3 | Downgrades | Buy → Hold |
| 04/19/2021 | 788.89% | Canaccord Genuity | $7 → $8 | Maintains | Buy |
| 04/15/2020 | 1122.22% | Canaccord Genuity | $12 → $11 | Maintains | Buy |
| 12/11/2019 | — | Mackie Research | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | 康託·菲茨傑拉德 | →$9 | 重申 | 超重→超重 |
| 07/03/2023 | 122.22% | 卡納科特·格納奇 | →$2 | 假設 | →保留 |
| 2022年11月17日 | 900% | 康託·菲茨傑拉德 | →$9 | 開始承保 | →超重 |
| 07/29/2021 | 233.33% | 卡納科特·格納奇 | $8→$3 | 評級下調 | 購買→Hold |
| 04/19/2021 | 788.89% | 卡納科特·格納奇 | $7→$8 | 維護 | 買 |
| 04/15/2020 | 1122.22% | 卡納科特·格納奇 | $12→$11 | 維護 | 買 |
| 2019年12月11日 | - | Mackie研究 | 升級 | 持有→購買 |
What is the target price for Theratechnologies (THTX)?
Therattech(THTX)的目標價是多少？
The latest price target for Theratechnologies (NASDAQ: THTX) was reported by Cantor Fitzgerald on July 13, 2023. The analyst firm set a price target for $9.00 expecting THTX to rise to within 12 months (a possible 900.00% upside). 3 analyst firms have reported ratings in the last year.
康託·菲茨傑拉德於2023年7月13日報道了Therattech(納斯達克代碼：THTX)的最新目標價。這家分析公司將目標價定為9美元，預計THTX將在12個月內上漲至(可能上漲900.00%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Theratechnologies (THTX)?
最新分析師對熱技術公司(THTX)的評級是多少？
The latest analyst rating for Theratechnologies (NASDAQ: THTX) was provided by Cantor Fitzgerald, and Theratechnologies reiterated their overweight rating.
納斯達克(Sequoia Capital：THTX)的最新分析師評級由康託·菲茨傑拉德提供，Therattech重申其增持評級。
When is the next analyst rating going to be posted or updated for Theratechnologies (THTX)?
下一次發佈或更新Therattech(THTX)分析師評級的時間是什麼時候？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Therattech的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。TheratTechnology的上一次評級是在2023年7月13日提交的，所以你應該預計下一次評級將在2024年7月13日左右提供。
Is the Analyst Rating Theratechnologies (THTX) correct?
分析師對科技股(THTX)的評級正確嗎？
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Therattech(THTX)評級被重申，目標價在0.00美元至9.00美元之間。THTX目前的交易價格為0.9美元，在分析師的預測範圍內。